Statistics

Total Visits

Views
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study76

Select a period of time:

Number of views in the range

Views
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study21

Views

Views
December 20252
January 20260
February 20260
March 20262
April 20266
May 20261
June 202610
Download CSV file
 untranslated
 untranslated

Top country views

Views
Netherlands8
United States7
Argentina1
Australia1
Germany1
Egypt1
Finland1
Romania1
 

Top cities views

Views
Groningen7
Los Angeles2
Ashburn1
Edison1
Frankfurt am Main1
Helsinki1
Nueve de Julio1
Tanta1
Tilburg1